To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with JavaScript enabled.
This website is not optimized for your browser, as configured.
Collaboration

Patient-Focused Drug Development: A Systematic Approach

Patient Focused Drug Development A Systematic Approach Feature Image

If you’ve been following us for a while, you may have noticed that our blog and Twitter content often points out that clinical research involves a partnership among many groups of people: sponsor companies (such as Lilly), study coordinators and principal investigators at clinical research sites, ethical review boards, and, of course, patients. The image we created on Lilly TrialGuide to illustrate the relationship among these various groups is meant to subtly show that the patient is at the center of clinical research. Who is involved in clinical trials

While health care providers may be experts on the clinical aspects of a given medical condition, patients are experts on what it is like to live with their condition. When we are developing a potential new treatment in a specific disease, we need to understand several key points:

  • What does it mean to the patient to have this disease or condition?
  • What do patients experience with this disease or condition?
  • What would a successful treatment look like from the patient’s perspective?

Patients have a unique viewpoint that can provide insights on the outcomes that matter most to them.

  • Severity and frequency of symptoms
  • Impact on daily function and daily life

PROAdapted Bullets 17Apr2019-01

This approach is aligned with upcoming guidance from the U.S. FDA on Patient-Focused Drug Development, or PFDD. PFDD is a systematic approach to help ensure that patients’ experiences, perspectives, needs, and priorities are captured and meaningfully incorporated into the development and evaluation of medical products, at all stages along the way.

For example, we often use patient questionnaires in our clinical research studies to collect information from the patient’s perspective. These patient questionnaires are one form of patient-reported outcomes, or PROs. A PRO is defined as “any report of the status of a patient’s health condition that comes directly from the patient, without interpretation of the patient’s response by a clinician or anyone else." Understanding the patient’s viewpoint through measures like PROs can be just as important as data we collect through things like laboratory samples (such as blood, urine, stool, or tissue) and imaging results (such as CT, MRI, or PET scans).

Patients are experts on what it is like to live with their condition, and we are making it a priority to listen to them. Drug development is at its best when we include the patient perspective throughout the process.

Tags: PROs,

Recent Articles

A Dose of Inspiration Podcast Feature Image

A Dose of Inspiration

Leigh Anne Naas Headshot
Leigh Anne Naas
May 17th, 20191 minute read

Clinical trials often present challenges, but we can find motivation in the experiences of others. Explore these resources to learn how folks from across the research community are making an impact.

Clinical Research Heart and Soul

Clinical Research Heart and Soul

Leigh Anne Naas Headshot
Leigh Anne Naas
May 8th, 20192 minute read

Past, present and future: research is at the heart and soul of what we do.

Join Our Digital Health Twitter Chat Feature Image

Tweetfest: Digital Health and Clinical Research

Leigh Anne Naas Headshot
Leigh Anne Naas
May 16th, 20193 minute read

What role will digital health play in the future of clinical research? Explore perspectives from folks across the clinical research community shared during our Twitter chat!

Patient Focused Drug Development A Systematic Approach Feature Image

Patient-Focused Drug Development: A Systematic Approach

Leigh Anne Naas Headshot
Leigh Anne Naas
May 2nd, 20192 minute read

HCPs may be experts on clinical aspects of a given medical condition, but patients are experts on what it’s like to live with it. This is why Patient-Focused Drug Development is so valuable.

Lab Samples - Like Clinical Research Gold Feature Image

Lab Samples: Like Clinical Research Gold

Leigh Anne Naas Headshot
Leigh Anne Naas
April 26th, 20194 minute read

Meet a Lilly clinical research scientist who uses her experience as a lab technologist every day to design trial protocols. While you may not think much of lab samples, to her, they are like gold!